Milestone Pharmaceuticals Inc.

MIST | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.90

-$0.02 (-1.94%)

Sep 22, 2026, 10:32 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	559K	238K	1.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	3.5M	1.5M	n/a	n/a	n/a	n/a	15M	n/a
Cost of Revenue	32K	70K	n/a	25K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	292K	9.73M	n/a	n/a
Gross Profit	527K	168K	1.55M	-25K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	3.5M	1.5M	n/a	n/a	-292K	-9.73M	15M	n/a
Operating Income	-25.63M	-23.77M	-17.26M	-11.9M	-12.53M	-20.52M	-12.35M	-9.62M	-9.66M	-10.48M	-13.8M	-15.36M	-16.44M	-15.5M	-13.76M	-15.03M	-16.81M	-14.05M	-17M	-14.27M	712K	-12.59M
Interest Income	1.74M	1.73M	833K	874K	516K	697K	904K	1.08M	1.19M	994K	1.05M	1.12M	1.21M	585K	582K	474K	158K	40K	34K	48K	58K	80K
Pretax Income	-28.61M	-26.18M	-17.41M	-12M	-12.97M	-20.76M	-12.36M	-9.44M	-9.36M	-10.35M	-13.61M	-15.08M	-16.04M	-14.95M	-13.18M	-14.56M	-16.65M	-14.01M	-16.96M	-14.23M	770K	-12.51M
Net Income	-28.61M	-26.07M	-17.41M	-11.92M	-12.97M	-20.76M	-12.36M	-9.44M	-9.36M	-10.35M	-13.61M	-15.08M	-16.04M	-14.95M	-13.18M	-14.56M	-16.65M	-14.01M	-16.88M	-14.23M	770K	-12.51M
Selling & General & Admin	22.65M	4.82M	13.28M	7.86M	8.86M	15.55M	8.41M	5.65M	6.85M	6.84M	8.35M	8.64M	7.81M	6.25M	6.19M	6.7M	6.15M	5.28M	5.8M	4.54M	4.86M	4M
Research & Development	3.51M	3.36M	5.52M	4.01M	3.67M	4.98M	3.94M	3.96M	2.82M	3.64M	5.45M	6.72M	8.62M	10.26M	10.71M	9.83M	10.66M	8.77M	10.9M	9.93M	9.51M	8.6M
Other Expenses	n/a	15.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	354K	n/a	n/a	n/a	n/a	-9.93M	-87K	n/a
Operating Expenses	26.16M	23.94M	18.8M	11.88M	12.53M	20.52M	12.35M	9.62M	9.66M	10.48M	13.8M	15.36M	16.44M	16.5M	17.26M	16.53M	16.81M	14.05M	16.71M	4.54M	14.29M	12.59M
Interest Expense	4.73M	4.14M	985K	967K	951K	935K	919K	903K	887K	872K	857K	841K	820K	33K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	8.2M	4.63M	5.1M	10.38M	4.41M	1.91M	1.8M	2.88M	4.98M	4.41M	3.37M	2.36M	2.56M	2.67M	2.23M	1.64M	n/a	1.58M	1.84M	1.37M
Cost & Expenses	26.19M	24.01M	18.8M	11.9M	12.53M	20.52M	12.35M	9.62M	9.66M	10.48M	13.8M	15.36M	16.44M	16.5M	17.26M	16.53M	16.81M	14.05M	17M	14.27M	14.29M	12.59M
Income Tax Expense	n/a	-109K	n/a	-73K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-80K	n/a	n/a	n/a
Shares Outstanding (Basic)	138.69M	130.29M	83.88M	66.38M	66.38M	66.29M	62.21M	66.19M	66.17M	50.16M	33.48M	42.97M	42.94M	42.85M	42.78M	42.49M	42.28M	42.24M	42.18M	42.19M	41.67M	41.26M
Shares Outstanding (Diluted)	138.69M	130.29M	83.88M	66.38M	66.38M	66.29M	62.21M	66.19M	66.17M	50.16M	33.48M	42.97M	42.94M	42.85M	42.78M	42.49M	42.28M	42.24M	42.18M	42.19M	44.53M	41.26M
EPS (Basic)	-0.21	-0.20	-0.16	-0.12	-0.20	-0.31	-0.20	-0.14	-0.14	-0.21	-0.41	-0.35	-0.37	-0.35	-0.31	-0.33	-0.39	-0.33	-0.40	-0.34	0.02	-0.30
EPS (Diluted)	-0.21	-0.20	-0.16	-0.12	-0.20	-0.31	-0.20	-0.14	-0.14	-0.21	-0.41	-0.35	-0.37	-0.35	-0.31	-0.33	-0.39	-0.33	-0.40	-0.34	0.02	-0.30
EBITDA	-23.83M	-21.98M	-16.39M	-11M	-11.99M	-19.8M	-11.42M	-8.51M	-8.45M	-9.45M	-12.73M	-14.22M	-15.2M	-14.9M	-13.16M	-14.53M	-16.62M	-13.98M	-16.67M	-14.2M	793K	-12.57M
EBIT	-23.89M	-22.04M	-16.42M	-11.03M	-12.02M	-19.83M	-11.44M	-8.54M	-8.48M	-9.48M	-12.75M	-14.24M	-15.22M	-14.92M	-13.18M	-14.56M	-16.65M	-14.01M	-16.96M	-14.23M	770K	-12.59M
Depreciation & Amortization	57K	56K	34K	25K	28K	27K	26K	25K	26K	28K	26K	24K	24K	18K	15K	27K	24K	23K	292K	24K	23K	23K